2026-04-13T01:19:40Zhttps://recercat.cat/oai/request

oai:recercat.cat:2072/4780092025-10-05T13:12:07Zcom_2072_98col_2072_378192

urn:hdl:2072/478009 Executive functions in binge spectrum eating disorders with comorbid compulsive buying Munguía, Lucero Lucas, Ignacio Jiménez-Murcia, Susana Mora-Maltas, Bernat Granero, Roser Miranda-Olivos, Romina Sánchez, Isabel Testa, Giulia Lozano Madrid, María Turton, Robert Menchón Magriñá, José Manuel Fernández Aranda, Fernando Binge spectrum disorders Compulsive buying Eating disorders Executive functions SDG 3 - Good Health and Well-being Altres ajuts: The authors would like to thank CERCA Programme/Generalitat de Catalunya for institutional support.This manuscript and research was supported by grants from (...) the Delegación del Gobierno para el Plan Nacional sobre Drogas (2017I067), the PERIS-SLT006/17/00246 grant, funded by the Department of Health of the Generalitat de Catalunya by the call 'Acció instrumental de programes de recerca orientats en l'àmbit de la recerca i la innovació en salut', and co-funded by FEDER funds/European Regional Development Fund (ERDF), a way to build Europe. CIBERObn is an initiative of ISCIII. Lucero Munguía is supported by a postdoctoral Grant of the Mexican Institution Consejo Nacional de Ciencia y Tecnología-CONACYT (Science and Technology National Counsel). María Lozano-Madrid is supported by a predoctoral grant of the Ministerio de Educación, Cultura y Deporte (FPU15/02911). Bernat Mora-Maltas is supported by a PRIME (Prevention and Remediation of Insulin Multimorbidity in Europe) project (ref. 847879). OBJECTIVE: The aims were to explore if bulimic spectrum disorders (BSD) patients, who also present comorbid compulsive buying (CB), could represent a specific subtype considering its neuropsychological performance; to present a descriptive analysis of different clinical features; and to explore how these variables could influence treatment outcome. It was hypothesised that the comorbid group will present worse neuropsychological performance that will lead to a worse treatment outcome. METHOD: The study has a longitudinal design. Women (N = 75) diagnosed with BSD, BSD + CB and Healthy Controls (HC); completed an evaluation of: cognitive flexibility, decision making, eating disorder (ED) symptomatology, psychopathological state and personality traits. RESULTS: BSD + CB was the group with the most severe clinical profile, worst treatment outcome and higher neuropsychological impairment, than other groups. Path-analysis evidenced that deficits in decision making were associated with bad treatment outcome, while deficits in flexibility with the presence of the comorbidity. Self-directedness and novelty seeking were associated with the neuropsychological performance and the comorbidity. CONCLUSION: BSD + CB exhibit a worse clinical and neuropsychological profile that seems to be related with the treatment outcome, which should be taken into account for the establishment of specific treatment approaches. 2021 Article Ministerio de Economía y Competitividad PSI2015-68701-R Instituto de Salud Carlos III PI17/01167 Instituto de Salud Carlos III PI20/00132 Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-1247 Ministerio de Educación, Cultura y Deporte FPU15/02911 European Commission 847879 European eating disorders review ; Vol. 29 Núm. 6 (2021), p. 854-867 open access Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. https://creativecommons.org/licenses/by/4.0/